Laxxon Medical to Attend 42nd Annual J.P. Morgan Healthcare Conference in San Francisco
- Dec 4, 2023
- 3 min
3D Screen Printing is Transforming Drug Manufacturing and Improving Patient Experiences
- Nov 27, 2023
- 4 min
What is First Pass Metabolism?
- Nov 16, 2023
- 3 min
Laxxon Medical joins German Accelerator’s Southeast Asia Market Access Class of 2023
- Nov 7, 2023
- 3 min
Drug Patents and Drug Exclusivity
- Nov 6, 2023
- 2 min
Laxxon Medical to Attend BIO-Europe Munich 2023
- Oct 17, 2023
- 3 min
Patient-Specific Drug Formulations Through 3D Screen Printing
- Oct 10, 2023
- 3 min
70% of Healthcare Patients Prefer Digital Communication
- Oct 3, 2023
- 3 min
Why Are Generic Pharmaceutical Drugs Important?
- Sep 11, 2023
- 4 min
Multi-Drug Combinations for Personalized Medicine with 3D Screen Printing
- Aug 28, 2023
- 3 min
3D Printing for Complex Drug Delivery Systems
- Aug 21, 2023
- 3 min
How Technology is Changing the World of Medicine
- Aug 14, 2023
- 2 min
Patient Education and Engagement with 3D Printed Pharmaceuticals
- Aug 7, 2023
- 3 min
Improving Drug Solubility and Bioavailability Through 3D Printing
- Jul 31, 2023
- 6 min
Advantages of 3D Printing In Pharmaceuticals
- Jun 1, 2023
- 1 min
Laxxon Medical to Participate in 2023 BIO International Convention
- May 31, 2023
- 5 min
Laxxon Medical Announces Formation of Scientific Advisory Board with Renowned Pharmaceutical Experts
- May 25, 2023
- 3 min
Overcoming Regulatory Challenges In 3D Printing of Pharmaceuticals
- May 1, 2023
- 4 min
Laxxon Medical's Commitment to Meeting and Exceeding CGMP Regulations In 3D Printed Pharmaceuticals
- Apr 6, 2023
- 2 min
CSO Achim Schneeberger Discusses the Development of Laxxon's Levodopa Project